Scientists at the Translational Genomics Research Institute, part of City of Hope, in collaboration with SIWA Therapeutics Inc., recently published results from a preclinical study that highlights the potential of SIWA318H, an advanced glycation end product-targeting antibody, for the treatment of pancreatic cancer.
Last week, The Cancer Letter interviewed City of Hope physician Ravi Salgia, who evacuated from his Eaton Canyon home with his wife on the evening of Jan. 7 due to approaching wildfires driven by the Santa Ana winds.
